MYO1G and acute lymphoblastic leukemia: At present, we are designing a study to evaluate the possible use of Myo1g in blood samples of patients to determine the usefulness as a diagnostic marker; in addition, we plan to design an ELISA test to determine the expression of Myo1g in serum or plasma samples from patients to determine its diagnostic use in ALL.